Annex II

United Kingdom

Index No International Chemical Identification EC No CAS No Classification Labelling Specific Conc. Limits, M-factors Notes
Hazard Class and Category Code(s) Hazard Statement Code(s) Pictogram, Signal Word Code(s) Hazard statement Code(s) Suppl. Hazard statement Code(s)
‘015-199-00-X tris[2-chloro-1-chloromethyl)ethyl] phosphate 237-159-2 13674-87-8 Carc. 2 H351
GSH08

Wng
H351
015-200-00-3 indium phosphide 244-959-5 22398-80-7
Carc. 1B

Repr. 2

STOT RE 1

H350

H361f

H372 (lungs)

GHS08

Dgr

H350

H361f

H372 (lungs)

STOT RE 1;

H372: C ≥0,1 %

Carc 1B;

H350: C ≥0,01 %

STOT RE 2;

H373: 0,01 % ≤ C < 0,1 %

015-201-00-9 trixylyl phosphate 246-677-8 25155-23-1 Repr. 1B H360F
GHS08

Dgr
H360F
015-202-00-4 tris(nonylphenyl) phosphite 247-759-6 26523-78-4
Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

015-203-00-X diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide 278-355-8 75980-60-8 Repr. 2 H361f (causing atrophy of the testes)
GHS08

Wng
H361f (causing atrophy of the testes)
602-109-00-4 Hexabromocyclododecane [1] 247-148-4 [1] 25637-99-4[1]
Repr. 2

Lact.

H361

H362

GHS08

Wng

H361

H362

1,2,5,6,9,10-hexabromocyclododecane [2] 221-695-9[2] 3194-55-6[2]
606-143-00-0 abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] _ [1] 71751-41-2 [1]
Repr. 2

Acute Tox. 2

Acute Tox. 1

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H361d

H300

H330

H372 (nervous system)

H400

H410

GHS06

GHS08

GHS09

Dgr

H361d

H300

H330

H372 (nervous system)

H410

STOT RE 1;

H372: C ≥ 5 %

STOT RE 2;

H373: 0,5 % ≤C<5 %

M = 10 000

avermectin B1a (purity ≥80 %); [2] 265-610-3 [2] 65195-55-3 [2]
606-144-00-6
acequinocyl (ISO);

3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate
— 57960-19-7
Skin Sens. 1

STOT SE 1

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H317

H370 (lung)

(inhalation)

H373 (blood system)

H400

H410

GHS07

GHS08

GHS09

Dgr

H317

H370 (lung)

(inhalation)

H373 (blood system)

H410
M = 1 000
607-698-00-1 4-tert-butylbenzoic acid 202-696-3 98-73-7
Repr. 1B

STOT RE 1

Acute Tox. 4

H360F

H372

H302

GHS07

GHS08

Dgr

H360F

H372

H302

612-281-00-2
leucomalachite green;

N,N,N',N'-tetramethyl-4,4'-benzylidenedianiline
204-961-9 129-73-7
Carc. 2

Muta. 2

H351

H341

GHS08

Wng

H351

H341

616-205-00-9
Metazachlor (ISO);

2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide
266-583-0 67129-08-2
Skin Sens. 1B

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H317

H351

H400

H410

GHS07

GHS08

GHS09

Wng

H317

H351

H410

M = 100

M = 100’

Index No	International Chemical Identification	EC No	CAS No	Classification		Labelling			Specific Conc. Limits, M-factors	Notes
Index No	International Chemical Identification	EC No	CAS No	Hazard Class and Category Code(s)	Hazard Statement Code(s)	Pictogram, Signal Word Code(s)	Hazard statement Code(s)	Suppl. Hazard statement Code(s)	Specific Conc. Limits, M-factors	Notes
‘015-199-00-X	tris[2-chloro-1-chloromethyl)ethyl] phosphate	237-159-2	13674-87-8	Carc. 2	H351	GSH08 Wng	H351
015-200-00-3	indium phosphide	244-959-5	22398-80-7	Carc. 1B Repr. 2 STOT RE 1	H350 H361f H372 (lungs)	GHS08 Dgr	H350 H361f H372 (lungs)		STOT RE 1; H372: C ≥0,1 % Carc 1B; H350: C ≥0,01 % STOT RE 2; H373: 0,01 % ≤ C < 0,1 %
015-201-00-9	trixylyl phosphate	246-677-8	25155-23-1	Repr. 1B	H360F	GHS08 Dgr	H360F
015-202-00-4	tris(nonylphenyl) phosphite	247-759-6	26523-78-4	Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H317 H400 H410	GHS07 GHS09 Wng	H317 H410
015-203-00-X	diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide	278-355-8	75980-60-8	Repr. 2	H361f (causing atrophy of the testes)	GHS08 Wng	H361f (causing atrophy of the testes)
602-109-00-4	Hexabromocyclododecane [1]	247-148-4 [1]	25637-99-4[1]	Repr. 2 Lact.	H361 H362	GHS08 Wng	H361 H362
602-109-00-4	1,2,5,6,9,10-hexabromocyclododecane [2]	221-695-9[2]	3194-55-6[2]	Repr. 2 Lact.	H361 H362	GHS08 Wng	H361 H362
606-143-00-0	abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1]	_ [1]	71751-41-2 [1]	Repr. 2 Acute Tox. 2 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1	H361d H300 H330 H372 (nervous system) H400 H410	GHS06 GHS08 GHS09 Dgr	H361d H300 H330 H372 (nervous system) H410		STOT RE 1; H372: C ≥ 5 % STOT RE 2; H373: 0,5 % ≤C<5 % M = 10 000
606-143-00-0	avermectin B1a (purity ≥80 %); [2]	265-610-3 [2]	65195-55-3 [2]		H361d H300 H330 H372 (nervous system) H400 H410	GHS06 GHS08 GHS09 Dgr	H361d H300 H330 H372 (nervous system) H410
606-144-00-6	acequinocyl (ISO); 3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate	—	57960-19-7	Skin Sens. 1 STOT SE 1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1	H317 H370 (lung) (inhalation) H373 (blood system) H400 H410	GHS07 GHS08 GHS09 Dgr	H317 H370 (lung) (inhalation) H373 (blood system) H410		M = 1 000
607-698-00-1	4-tert-butylbenzoic acid	202-696-3	98-73-7	Repr. 1B STOT RE 1 Acute Tox. 4	H360F H372 H302	GHS07 GHS08 Dgr	H360F H372 H302
612-281-00-2	leucomalachite green; N,N,N',N'-tetramethyl-4,4'-benzylidenedianiline	204-961-9	129-73-7	Carc. 2 Muta. 2	H351 H341	GHS08 Wng	H351 H341
616-205-00-9	Metazachlor (ISO); 2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide	266-583-0	67129-08-2	Skin Sens. 1B Carc. 2 Aquatic Acute 1 Aquatic Chronic 1	H317 H351 H400 H410	GHS07 GHS08 GHS09 Wng	H317 H351 H410		M = 100 M = 100’